Linda Sleire
Bergen, 5021, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Phase I trial combining sulfasalazine and gamma knife radiosurgery for recurrent glioblastoma.
Journal: MethodsX
Published: January 28, 2026
Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts.
Journal: BMC cancer
Published: July 22, 2016
Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats.
Journal: Journal of neuro-oncology
Published: November 23, 2015
Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models.
Journal: BMC cancer
Published: September 28, 2015
Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.
Journal: Oncogene
Published: July 11, 2014
Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model.
Journal: BioMed research international
Published: April 20, 2013
Establishment of a novel dsRed NOD/Scid mouse strain to investigate the host and tumor cell compartments.
Journal: Cancer investigation
Published: March 26, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026